Search

Your search keyword '"Slama, Laurence"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Slama, Laurence" Remove constraint Author: "Slama, Laurence"
215 results on '"Slama, Laurence"'

Search Results

1. Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

3. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

4. Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIV

5. Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV

6. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

7. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study

9. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

10. Incident Proteinuria by HIV Serostatus Among Men With Pre-–Diabetes Mellitus: The Multicenter AIDS Cohort Study.

13. Changes in bone turnover markers with HIV seroconversion and ART initiation.

14. Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men

15. Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.

17. HIV infection and COVID-19: risk factors for severe disease

18. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

19. Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort

20. Additional file 4 of Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users

21. Additional file 1 of Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users

22. Additional file 3 of Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users

23. Additional file 2 of Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users

25. Impact on renal function of daily and on-demand HIV pre-exposure prophylaxis in the ANRS-PREVENIR study

27. Smoking‐associated morbidities on computed tomography lung cancer screens in HIV‐infected smokers

28. A highly virulent variant of HIV-1 circulating in the Netherlands

30. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

31. Striking Differences in Weight Gain after Cart Initiation Depending on Early or Late Presentation: Results from the ANRS CO4 FHDH Cohort

50. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso

Catalog

Books, media, physical & digital resources